Abstract
Objective: The present study assessed the prevalence of adverse drug reactions (ADRs) among HIV positive patients taking antiretroviral therapy referred to Imam Khomeini Hospital in Tehran, Iran.
Methods: This is a cross sectional study regarding side effects of Highly Active Antiretroviral Therapy (HAART) in HIV positive patients referred to Voluntary Counseling and Testing (VCT) center in Imam Khomeini Hospital of Tehran, Iran during a period of the year 2009 to 2010. Two hundred patients under antiretroviral treatment evaluated for the side effects of drug based on available records, face to face interviews and written lab data. Results: Data was collected from a sample of 200 HIV positive patients (72% male). Injection drug use was the most common route of HIV transmission. Co-Infections with Hepatitis C virus (HCV) found in the majority of patients (60.5%). Tuberculosis was the most prevalent opportunistic infection. One hundred eighty eight (94%) patients experienced at least one adverse drug reaction. The most frequent clinical and paraclinical findings were skin rash (28%) and abnormal liver function tests (36%). Conclusion: Given the high prevalence of adverse drug reactions among HIV positive patients taking antiretroviral therapy (ART) in this study, clinicians should be aware of ADRs at the initiation of ART as complications can affect patients’ adherence to the therapy.Keywords: HIV, adverse drug reaction, antiretroviral therapy, prevalence, clinical, paraclinical.
Infectious Disorders - Drug Targets
Title:Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran
Volume: 17 Issue: 2
Author(s): Hamid E. Koochak, Azita Babaei, Alia Pourdast, Raheleh Golrokhy, Mehrnaz Rasoolinejad, Sepideh Khodaei, Saeed R. J. Moghadam*, Reza R. Taheri and Seyed Ahmad Seyed Alinaghi
Affiliation:
- Ziaeian Hospital, Abouzar St., Tehran,Iran
Keywords: HIV, adverse drug reaction, antiretroviral therapy, prevalence, clinical, paraclinical.
Abstract: Objective: The present study assessed the prevalence of adverse drug reactions (ADRs) among HIV positive patients taking antiretroviral therapy referred to Imam Khomeini Hospital in Tehran, Iran.
Methods: This is a cross sectional study regarding side effects of Highly Active Antiretroviral Therapy (HAART) in HIV positive patients referred to Voluntary Counseling and Testing (VCT) center in Imam Khomeini Hospital of Tehran, Iran during a period of the year 2009 to 2010. Two hundred patients under antiretroviral treatment evaluated for the side effects of drug based on available records, face to face interviews and written lab data. Results: Data was collected from a sample of 200 HIV positive patients (72% male). Injection drug use was the most common route of HIV transmission. Co-Infections with Hepatitis C virus (HCV) found in the majority of patients (60.5%). Tuberculosis was the most prevalent opportunistic infection. One hundred eighty eight (94%) patients experienced at least one adverse drug reaction. The most frequent clinical and paraclinical findings were skin rash (28%) and abnormal liver function tests (36%). Conclusion: Given the high prevalence of adverse drug reactions among HIV positive patients taking antiretroviral therapy (ART) in this study, clinicians should be aware of ADRs at the initiation of ART as complications can affect patients’ adherence to the therapy.Export Options
About this article
Cite this article as:
Koochak E. Hamid, Babaei Azita, Pourdast Alia, Golrokhy Raheleh, Rasoolinejad Mehrnaz, Khodaei Sepideh , Moghadam R. J. Saeed*, Taheri R. Reza and Seyed Alinaghi Seyed Ahmad, Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran, Infectious Disorders - Drug Targets 2017; 17 (2) . https://dx.doi.org/10.2174/1871526517666170117111350
DOI https://dx.doi.org/10.2174/1871526517666170117111350 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
Call for Papers in Thematic Issues
New Frontiers in Infectious Disease Research: Small-Molecule Probes and Biomarker Identification
The biological relevance of small-molecule chemical probes targeting a disease model is crucial in the early stages of drug discovery. The integration of omics technologies such as genomics, proteomics, metabolomics, immunomic, and cellular levels has greatly enhanced the ability to identify novel biomarkers and understand the complex interactions between pathogens ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Bio-Psycho-Social Dimension in Women’s Sexual Desire: ‘Argumentum ad novitatem’
Current Drug Targets The Efficacy and Potential Mechanisms of Chinese Herbal Medicine on Irritable Bowel Syndrome
Current Pharmaceutical Design Prevention of Intracerebral Haemorrhage
Current Drug Targets Structure Based Identification of Potential Inhibitors of NS3 Protein of Zika Virus
Letters in Drug Design & Discovery Adalimumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer’s Disease
Current Drug Targets Janus Molecule I: Dichotomous Effects of COMT in Neuropathic vs Nociceptive Pain Modalities
CNS & Neurological Disorders - Drug Targets Neurobrucellosis: A Case Report with an Unusual Presentation
Recent Advances in Anti-Infective Drug Discovery Helicobacter pylori Current Chemotherapy and New Targets for Drug Design
Current Pharmaceutical Design Therapeutic Strategies for Treatment of Inflammation-related Depression
Current Neuropharmacology Cutaneous Complications of Anderson-Fabry Disease
Current Pharmaceutical Design Dystonia Associated with Lamotrigine Therapy: A Case Report and Review of the Literature
Current Drug Safety Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease
Current Pharmaceutical Design Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment
Current Pharmaceutical Design Glucocorticoid Receptor Antagonists
Current Topics in Medicinal Chemistry Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Current Neuropharmacology Signal Pathways Mediating Antidepressant and Antipsychotic Drugs on Neuronal Cell Survival
Current Medicinal Chemistry - Central Nervous System Agents Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review
Current Alzheimer Research Clinical Observation of Electroencephalographic Changes and Risk of Convulsion Occurrence in Children Receiving Neural Precursor Cell Transplantation
CNS & Neurological Disorders - Drug Targets